These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18335034)

  • 1. Transcriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment.
    Yang N; Huang J; Greshock J; Liang S; Barchetti A; Hasegawa K; Kim S; Giannakakis A; Li C; O'Brien-Jenkins A; Katsaros D; Bützow R; Coukos G; Zhang L
    PLoS One; 2008 Mar; 3(3):e1758. PubMed ID: 18335034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIK3CA alterations in Middle Eastern ovarian cancers.
    Abubaker J; Bavi P; Al-Haqawi W; Jehan Z; Munkarah A; Uddin S; Al-Kuraya KS
    Mol Cancer; 2009 Jul; 8():51. PubMed ID: 19638206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop.
    Thakur B; Ray P
    J Exp Clin Cancer Res; 2017 Nov; 36(1):164. PubMed ID: 29169370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of HDAC-Mediated Repression and Gain of NF-κB Activation Underlie Cytokine Induction in ARID1A- and PIK3CA-Mutation-Driven Ovarian Cancer.
    Kim M; Lu F; Zhang Y
    Cell Rep; 2016 Sep; 17(1):275-288. PubMed ID: 27681437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer.
    Astanehe A; Arenillas D; Wasserman WW; Leung PC; Dunn SE; Davies BR; Mills GB; Auersperg N
    J Cell Sci; 2008 Mar; 121(Pt 5):664-74. PubMed ID: 18270270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms.
    Nakayama K; Nakayama N; Kurman RJ; Cope L; Pohl G; Samuels Y; Velculescu VE; Wang TL; Shih IeM
    Cancer Biol Ther; 2006 Jul; 5(7):779-85. PubMed ID: 16721043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.
    Zhang L; Yang N; Katsaros D; Huang W; Park JW; Fracchioli S; Vezzani C; Rigault de la Longrais IA; Yao W; Rubin SC; Coukos G
    Cancer Res; 2003 Jul; 63(14):4225-31. PubMed ID: 12874030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer.
    Woenckhaus J; Steger K; Sturm K; Münstedt K; Franke FE; Fenic I
    Virchows Arch; 2007 Apr; 450(4):387-95. PubMed ID: 17377809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.
    Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
    Virchows Arch; 2012 Jan; 460(1):77-87. PubMed ID: 22120431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
    Wu RC; Ayhan A; Maeda D; Kim KR; Clarke BA; Shaw P; Chui MH; Rosen B; Shih IeM; Wang TL
    J Pathol; 2014 Mar; 232(4):473-81. PubMed ID: 24338723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
    Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
    Mod Pathol; 2012 Apr; 25(4):615-24. PubMed ID: 22157930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
    Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.
    Liang S; Yang N; Pan Y; Deng S; Lin X; Yang X; Katsaros D; Roby KF; Hamilton TC; Connolly DC; Coukos G; Zhang L
    PLoS One; 2009; 4(1):e4295. PubMed ID: 19172191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.
    Kolasa IK; Rembiszewska A; Felisiak A; Ziolkowska-Seta I; Murawska M; Moes J; Timorek A; Dansonka-Mieszkowska A; Kupryjanczyk J
    Cancer Biol Ther; 2009 Jan; 8(1):21-6. PubMed ID: 19029838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
    Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
    APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.
    Kinross KM; Montgomery KG; Kleinschmidt M; Waring P; Ivetac I; Tikoo A; Saad M; Hare L; Roh V; Mantamadiotis T; Sheppard KE; Ryland GL; Campbell IG; Gorringe KL; Christensen JG; Cullinane C; Hicks RJ; Pearson RB; Johnstone RW; McArthur GA; Phillips WA
    J Clin Invest; 2012 Feb; 122(2):553-7. PubMed ID: 22214849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathway.
    Cizkova M; Cizeron-Clairac G; Vacher S; Susini A; Andrieu C; Lidereau R; Bièche I
    PLoS One; 2010 Dec; 5(12):e15647. PubMed ID: 21209903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.
    Yang M; Zou J; Zhu H; Liu S; Wang H; Bai P; Xiao X
    Oncol Rep; 2015 May; 33(5):2190-8. PubMed ID: 25760800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PIK3CA gene is mutated with high frequency in human breast cancers.
    Bachman KE; Argani P; Samuels Y; Silliman N; Ptak J; Szabo S; Konishi H; Karakas B; Blair BG; Lin C; Peters BA; Velculescu VE; Park BH
    Cancer Biol Ther; 2004 Aug; 3(8):772-5. PubMed ID: 15254419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation.
    Hutti JE; Pfefferle AD; Russell SC; Sircar M; Perou CM; Baldwin AS
    Cancer Res; 2012 Jul; 72(13):3260-9. PubMed ID: 22552288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.